Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,545,533
  • Shares Outstanding, K 104,475
  • Annual Sales, $ 4,676 M
  • Annual Income, $ 131,260 K
  • 60-Month Beta 1.74
  • Price/Sales 1.21
  • Price/Cash Flow 10.41
  • Price/Book 1.88
Trade SYNH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.96
  • Number of Estimates 5
  • High Estimate 0.98
  • Low Estimate 0.93
  • Prior Year 0.93
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.04 +4.00%
on 10/29/20
62.21 -14.68%
on 10/14/20
-0.08 (-0.15%)
since 09/30/20
3-Month
50.26 +5.60%
on 09/24/20
66.31 -19.95%
on 08/06/20
-9.60 (-15.32%)
since 07/30/20
52-Week
30.02 +76.82%
on 03/18/20
74.25 -28.51%
on 03/04/20
-0.86 (-1.59%)
since 10/30/19

Most Recent Stories

More News
Syneos Health (SYNH) Tops Q3 Earnings Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 15.56% and -1.92%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 53.08 (-1.96%)
Syneos Health Reports Third Quarter 2020 Results

Highlights

SYNH : 53.08 (-1.96%)
Syneos Health, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 29, 2020 / Syneos Health, Inc. (NASDAQ:SYNH) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 29, 2020 at 8:00...

SYNH : 53.08 (-1.96%)
Amulet Capital Backed Synteract To Be Acquired by Syneos Health

Amulet Capital Partners, LP ("Amulet"), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced today that it has entered into a definitive...

SYNH : 53.08 (-1.96%)
Syneos Health to Acquire Synteract, a Top CRO Provider to Emerging Biopharma

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 53.08 (-1.96%)
Syneos Health(R) Launches Kinetic(TM) Omnichannel Capability to Accelerate Modern Customer Engagement

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today introduced Kinetic, a modern customer engagement capability that makes fully integrated omnichannel...

SYNH : 53.08 (-1.96%)
Syneos Health Named to Forbes 2020 List of World's Best Employers

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the Company has been named to the Forbes 2020 list of World's Best Employers, ranking highest...

SYNH : 53.08 (-1.96%)
Syneos Health Wins Society for Clinical Research Sites Eagle Award for Fourth Consecutive Year

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it was awarded the Society for Clinical Research Sites (SCRS) Eagle Award, sweeping...

SYNH : 53.08 (-1.96%)
Syneos Health Schedules Third Quarter 2020 Earnings Call for Thursday, October 29, 2020

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2020 financial results on Thursday, October 29, 2020, prior to its earnings...

SYNH : 53.08 (-1.96%)
Syneos Health Banks on Essential Therapies Amid Coronavirus Woe

Syneos Health's (SYNH) over 70% of clinical businesses comprise essential therapeutic areas that are experiencing reduced impacts of coronavirus outbreak.

HOLX : 68.82 (-2.38%)
QGEN : 47.44 (-0.34%)
TMO : 473.12 (+0.26%)
SYNH : 53.08 (-1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 57.41
1st Resistance Point 55.24
Last Price 53.08
1st Support Level 51.60
2nd Support Level 50.13

See More

52-Week High 74.25
Fibonacci 61.8% 57.35
Last Price 53.08
Fibonacci 50% 52.14
Fibonacci 38.2% 46.92
52-Week Low 30.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar